Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "National Drug Agency"


2 mentions found


Cemeteries are bolstering their security measures because gravediggers are stealing human bones to make powerful synthetic drugs, local journalists told Business Insider. AdvertisementA vendor sells daily necessities at a market in Freetown, Sierra Leone, Feb. 21, 2024. Formaldehyde also has euphoric properties, says the National Library of Medicine, which explains why kush users could be raiding Freetown's cemeteries. JOHN WESSELS | Getty ImagesJalloh noted that the use of synthetic drugs was not unique to Sierra Leone. ReutersIn 2015, BI's Erin Brodwin covered the rise of these synthetic drugs, marketed as "spice," "K2," "black mamba," or "crazy clown."
Persons: , Sierra, Julius Maada, Michael Cole, Sally Hayden, JOHN WESSELS, Cole, Mabinty Magdalene Kamar, Abdul Jalloh, HUGH KINSELLA CUNNINGHAM, Thomas Dixon, Jalloh, Salifu Kamara, kush, BI's Erin Brodwin, Brodwin, tranq Organizations: Service, Business, Xinhua News Agency, Getty, Anglia Ruskin University, The Irish Times, National Library of Medicine, Politico, Sierra, Sierra Leone Psychiatric Teaching Hospital, Police, Getty Images Local, Salone Times, BBC, Freetown Police Force, National Drug Agency, NPR, Guardian, Disease Control, Prevention, Reuters, Financial Times Locations: Freetown, African, Sierra Leone, West Africa, Mabinty, Waterloo , Sierra Leone, kush, New York City, New York, Kensington, North Philadelphia
French drug agency says under investigation over thyroid drug
  + stars: | 2022-12-06 | by ( ) www.reuters.com   time to read: +1 min
[1/2] The logo of German pharmaceuticals company Merck is seen in front of the company's headquarters in Darmstadt, Germany, May 16, 2016. REUTERS/Kai Pfaffenbach/File PhotoCompanies Merck KGaA FollowPARIS, Dec 6 (Reuters) - France's ANSM national drug agency said it is under formal investigation on suspicion of issuing misleading information regarding German drugmaker Merck's (MRCG.DE) thyroid drug Levothyrox, adding it contested the provisional charges. The French Association of Thyroid Patients on Tuesday welcomed the development, but expressed disappointment that the provisional charges had not been more far-reaching. A court in the French city of Marseille had in October already placed Merck under formal investigation, meaning it is treated as a formal suspect but the case may yet be dropped. Merck said in October the investigation against it did not concern in any way the new formula for Levothyrox, but the way it provided information when changing from the old one.
Total: 2